Research Question: To what extent does the pharmaceutical company Mylan have a corporate social responsibility to their customers when pricing EpiPen’s?

Section 1: Introduction

Sub-topic 1: What is my research question

Sub-topic 2: What is the relevance of my question

Sub-topic 3: Link to real life

Section 2: How Medicine Prices Are Set

Sub-topic 4: Why medicine prices are so high?

Source: Bad Pharma chapter 2 "Where do new drugs come from?"

Sub-topic 5: How pharmaceutical companies define the price of their medicine

Sub-topic 6: The role of Insurance companies in Health Industry

Section 3: How Do These Prices Effect Customers

Sub-topic 7: The negative impacts

Sub-topic 8: Research findings and supporting data of these prices

Section 4: Corporate Social Responsibility

Sub-topic 9: What is it, how it works?

Sub-topic 10: What aspects of CSR cause limitations?

Sub-topic 11: Does CSR negatively affect profitability?

Section 5: Mylan

Sub-topic 10: Mylan and their business practices

Sub-topic 11: Other medicines and their prices

Section 6: EpiPen

Sub-topic 12: The importance of EpiPen

Sub-topic 13: History of its prices

Sub-topic 14: Break-even chart comparisons

• Compare different prices and find their break-even point

Sub-topic 15: Profitability ratios

• Compare different years and their profitabilities

Section 7: Conclusion

Sub-topic 16: Summary of the findings

Sub-topic 17: Implications to the real world